Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine concentration and rebound pain after interscalene block for shoulder arthroscopy
ChiCTR2200055510Phase 4Recruiting
- Sponsor
- Chengdu Fifth People's Hospital
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain and Rebound pain (2 arms), sponsored by Chengdu Fifth People's Hospital. Primary endpoint: Incidence of rebound pain within 24 hours after operation. Started Jan 2022; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative painRebound pain
Beyond the preview
Go deeper on ChiCTR2200055510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055510.